Behavioral changes and brain energy metabolism dysfunction in rats treated with methamphetamine or dextroamphetamine

Neuroscience Letters

Volumn 530, Issue 1, 2012, Pages 75-79

  Feier, Gustavo ^a   Valvassori, Samira S ^a   Lopes Borges, Jéssica ^a   Varela, Roger B ^a   Bavaresco, Daniela V ^a   Scaini, Giselli ^a   Morais, Meline O ^a   Andersen, Monica L ^b   Streck, Emilio L ^a   Quevedo, João ^a  

^a UNIVERSITY OF SOUTHERN SANTA CATARINA   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Dextroamphetamine; Krebs cycle enzymes; Methamphetamine; Mitochondrial chain

Indexed keywords

CITRATE SYNTHASE; DEXAMPHETAMINE; METHAMPHETAMINE; SUCCINATE DEHYDROGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BEHAVIOR CHANGE; BRAIN; BRAIN DYSFUNCTION; BRAIN ENERGY METABOLISM DYSFUNCTION; BRAIN REGION; CONTROLLED STUDY; DRUG MEGADOSE; DRUG POTENCY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SNIFFING; STEREOTYPY;

AMPHETAMINE-RELATED DISORDERS; AMYGDALA; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; CITRIC ACID CYCLE; CORPUS STRIATUM; DEXTROAMPHETAMINE; ENERGY METABOLISM; HIPPOCAMPUS; MALE; METHAMPHETAMINE; MITOCHONDRIA; OXIDATIVE STRESS; PREFRONTAL CORTEX; RATS; RATS, WISTAR;

EID: 84868301418     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.09.039     Document Type: Article

References (51)

1. Adam-Vizi V. Production of reactive oxygen species in brain mitochondria: contribution by electron transport chain and non-electron transport chain sources. Antioxidants and Redox Signalling 2005, 7:1140-1149.
2. Andreazza A.C., Kauer-Sant'Anna M., Frey B.N., Stertz L., Zanotto C., Ribeiro L., Giasson K., Valvassori S.S., Réus G.Z., Salvador M., Quevedo J., Gonçalves C.A., Kapczinski F. Effects of mood stabilizers on DNA damage in an animal model of mania. Journal of Psychiatry and Neuroscience 2008, 33(6):516-524.
3. Bachmann R.F., Wang Y., Yuan P., Zhou R., Li X., Alesci S., Du J., Manji H.K. Common effects of lithium and valproate on mitochondrial functions: protection against methamphetamine-induced mitochondrial damage. International Journal of Neuropsychopharmacology 2009, 12:805-822.
4. Baumann M.H., Clark R.D., Rothman R.B. Locomotor stimulation produced by 3,4-methylenedioxymethamphetamine (MDMA) is correlated with dialysate levels of serotonin and dopamine in rat brain. Pharmacology Biochemistry and Behavior 2008, 90:208-217.
5. Beaulieu J.M., Sotnikova T.D., Yao W.D., Kockeritz L., Woodgett J.R., Gainetdinov R.R., Caron M.G. Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:5099-5104.
6. Beauvais G., Atwell K., Jayanthi S., Ladenheim B., Cadet J.L. Involvement of dopamine receptors in binge methamphetamine-induced activation of endoplasmic reticulum and mitochondrial stress pathways. PLoS ONE 2011, 6(12):28946.
7. Calabrese V., Scapagnini G., Giuffrida Stella A.M., Bates T.E., Clark J.B. Mitochondrial involvement in brain function and dysfunction: relevance to aging, neurodegenerative disorders and longevity. Neurochemical Research 2001, 6:739-764.
8. Cassina A., Radi R. Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport. Archives of Biochemistry and Biophysics 1996, 328:309-316.
9. Clay H.B., Sillivan S., Konradi C. Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia. International Journal of Developmental Neuroscience 2011, 29(3):311-324.
10. da-Rosa D.D., Valvassori S.S., Steckert A.V., Arent C.O., Ferreira C.L., Lopes-Borges J., Varela R.B., Mariot E., Dal-Pizzol F., Andersen M.L., Quevedo J. Differences between dextroamphetamine and methamphetamine: behavioral changes and oxidative damage in brain of Wistar rats. Journal of Neural Transmission 2012, 119:31-38.
11. da-Rosa D.D., Valvassori S.S., Steckert A.V., Ornell F., Ferreira C.L., Lopes-Borges J., Varela R.B., Dal-Pizzol F., Andersen M.L., Quevedo J. Effects of lithium and valproate on oxidative stress and behavioral changes induced by administration of m-AMPH. Psychiatry Research 2012, 17.
12. Di Chiar G. Nucleus accumbens shell and core dopamine: differential role in behavior and addiction. Behavioural Brain Research 2002, 137:75-114.
13. Einat H., Yuan P., Dogra S., Manji H.K. Does the PKC signaling pathway play a role in the pathophysiology and treatment of bipolar disorder?. Biological Psychiatry 2003, 53:S-399.
14. Ericson E., Samuelsson J., Ahlenius S. Photocell measurements of rat motor activity. A contribution to sensitivity and variation in behavioral observations. Journal of Pharmacological Methods 1991, 25:111-122.
15. Finsterer J. Cognitive dysfunction in mitochondrial disorders. Acta Neurologica Scandinavica 2012, 126(1):1-11.
16. Fischer J.C., Ruitenbeek W., Berden J.A., Trijbels J.M., Veerkamp J.H., Stadhouders A.M., Sengers R.C., Janssen A.J. Differential investigation of the capacity of succinate oxidation in human skeletal muscle. Clinica Chimica Acta 1985, 153:23-26.
17. Frey B.N., Valvassori S.S., Réus G.Z., Martins M.R., Petronilho F.C., Bardini K., Dal-Pizzol F., Kapczinski F., Quevedo J. Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania. Journal of Psychiatry and Neuroscience 2006, 31(5):326-332.
18. Fukami G., Hashimoto K., Koike K., Okamura N., Shimizu E., Iyo M. Effect of antioxidant N-acetyl-l-cysteine on behavioral changes and neurotoxicity in rats after administration of methamphetamine. Brain Research 2004, 1016(1):90-95.
19. Gluck M.R., Moy L.Y., Jayatilleke E., Hogan K.A., Manzino L., Sonsalla P.K. Parallel increases in lipid and protein oxidative markers in several mouse brain regions after methamphetamine treatment. Journal of Neurochemistry 2001, 79:152-160.
20. Hall D., Powers J., Gulley J. Blockade of D1 dopamine receptors in the medial prefrontal cortex attenuates amphetamine- and methamphetamine-induced locomotor activity in the rat. Brain Research 2009, 1300:51-57.
21. Hedou G., Homberg J., Feldon J., Heidbreder C.A. Expression of sensitization to amphetamine and dynamics of dopamine neurotransmission in different laminae of the rat medial prefrontal cortex. Neuropharmacology 2001, 40(3):366-382.
22. Izawa J., Yamanashi K., Asakura T., Misu Y., Goshima Y. Differential effects of methamphetamine and cocaine on behavior and extracellular levels of dopamine and 3,4-dihydroxyphenylalanine in the nucleus accumbens of conscious rats. European Journal of Pharmacology 2006, 549:84-90.
23. Jou S.H., Chiu N.Y., Liu C.S. Mitochondrial dysfunction and psychiatric disorders. Chang Gung Medical Journal 2009, 32(4):370-379.
24. Kalueff A.V., Aldridge J.W., LaPorte J.L., Murphy D.L., Tuohimaa P. Analyzing rooming microstructure in neurobehavioral experiments. Nature Protocols 2007, 2:2538-2544.
25. Kitto G.B. Intra- and extramitochondrial malate dehydrogenases from chicken and tuna heart. Methods in Enzymology 1969, 23:106-116.
26. Kumar P., Kalonia H., Kumar A. Nitric oxide mechanism in the protective effect of antidepressants against 3-nitropropionic acid-induced cognitive deficit, glutathione and mitochondrial alterations in animal model of Huntington's disease. Behavioural Pharmacology 2010, 21(3):217-230.
27. LaVoie M.J., Hastings T.G. Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine. Journal of Neuroscience 1999, 19:1484-1491.
28. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 1951, 193:265-275.
29. Mattiasson G., Shamloo M., Gido G., Mathi K., Tomasevic G., Yi S., Warden C.H., Castilho R.F., Melcher T., Gonzalez-Zulueta M., Nikolich K., Wieloch T. Uncoupling protein-2 prevents neuronal death and diminishes brain dysfunction after stroke and brain trauma. Nature 2003, 9:1062-1068.
30. Moretti M., Valvassori S.S., Steckert A.V., Rochi N., Benedet J., Scaini G., Kapczinski F., Streck E.L., Zugno A.I., Quevedo J. Tamoxifen effects on respiratory chain complexes and creatine kinase activities in an animal model of mania. Pharmacology Biochemistry and Behavior 2011, 98(2):304-310.
31. Pierce R.C., Kalivas P.W. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Research. Brain Research Reviews 1997, 25:192-216.
32. Robinson T.E., Jurson P.A., Bennett J.A., Bentgen K.M. Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)-amphetamine: a microdialysis study in freely moving rats. Brain Research 1988, 462(2):211-222.
33. Rustin P., Chretien D., Bourgeron T., Gérard B., Rötig A., Saudubray J.M., Munnich A. Biochemical and molecular investigations in respiratory chain deficiencies. Clinica Chimica Acta 1994, 228:35-51.
34. Sellings L.H., Clarke P.B. Segregation of amphetamine reward and locomotor stimulation between nucleus accumbens medial shell and core. Journal of Neuroscience 2003, 23:6295-6303.
35. Shepherd D., Garland P.B. The kinetic properties of citrate synthase from rat liver mitochondria. Biochemical Journal 1996, 114:597-610.
36. Shima N., Miyawaki I., Bando K., Horie H., Zaitsu K., Katagi M., Bamba T., Tsuchihashi H., Fukusaki E. Influences of methamphetamine-induced acute intoxication on urinary and plasma metabolic profiles in the rat. Toxicology 2011, 287:29-37.
37. Simon N.W., Montgomery K.S., Beas B.S., Mitchell M.R., Lasarge C.L., Mendez I.A., Bañuelos C., Vokes C.M., Taylor A.B., Haberman R.P., Bizon J.L., Setlow B. Dopaminergic modulation of risky decision-making. Journal of Neuroscience 2011, 30:17460-17470.
38. Spina M.B., Cohen G. Dopamine turnover and glutathione oxidation: implications for Parkinson disease. Proceedings of the National Academy of Sciences of the United States of America 1989, 86:1398-1400.
39. Strakowski S.M., DelBello M.P., Adler C., Cecil K.M., Sax K.W. Neuroimaging in bipolar disorder. Bipolar Disorders 2000, 2:148-164.
40. Strakowski S.M., Delbello M.P., Adler C.M. The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings. Molecular Psychiatry 2005, 10:105-116.
41. Sulzer D., Rayport S. Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action. Neuron 1990, 5:797-808.
42. Tan H., Young L.T., Shao L., Che Y., Honer W.G., Wang J.F. Mood stabilizer lithium inhibits amphetamine-increased 4-hydroxynonenal-protein adducts in rat frontal cortex. International Journal of Neuropsychopharmacology 2011, 23:1-11.
43. Tyler D. The Mitochondrion in Health and Diseases 1992, VCH Publishers, New York.
44. Valenzuela A., Pla A., Villanueva E. Effects of chronic administration of dextroamphetamine on enzymes of energy metabolism in regions of the rat brain. Neuropharmacology 1987, 26:627-631.
45. Valvassori S.S., Rezin G.T., Ferreira C.L., Moretti M., Gonçalves C.L., Cardoso M.R., Streck E.L., Kapczinski F., Quevedo J. Effects of mood stabilizers on mitochondrial respiratory chain activity in brain of rats treated with d-amphetamine. Journal of Psychiatric Research 2010, 44:903-909.
46. Valvassori S.S., Rezin G.T., Ferreira C.L., Moretti M., Gonçalves C.L., Cardoso M.R., Streck E.L., Kapczinski F., Quevedo J. Effects of mood stabilizers on mitochondrial respiratory chain activity in brain of rats treated with d-amphetamine. Journal of Psychiatric Research 2010, 44(14):903-909.
47. Vanderschuren L.J., Kalivas P.W. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology 2000, 151(2-3):99-120.
48. White I.M., Whitaker C., White W. Amphetamine-induced hyperlocomotion in rats: hippocampal modulation of the nucleus accumbens. Hippocampus 2006, 16:596-603.
49. Woods V.E., Ettenberg A. Increased amphetamine-induced locomotion during inactivation of the basolateral amygdala. Behavioural Brain Research 2004, 149:33-39.
50. Wrona M.Z., Yang Z., Zhang F., Dryhurst G. Potential new insights into the molecular mechanisms of methamphetamine-induced neurodegeneration. NIDA Research Monograph 1997, 173:146-174.
51. Zolkowska D., Jain R., Rothman R.B., Partilla J.S., Roth B.L., Setola V., Prisinzano T.E., Baumann M.H. Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil. Journal of Pharmacology and Experimental Therapeutics 2009, 329:738-776.